Add Formweb to your mobile device
Search results for:
fentaNYL
fentaNYL
| Drug Name | Form | Strength | Notes |
|---|---|---|---|
| FentaNYL | FILM, EXTENDED RELEASE, TRANSDERMAL | 12 mcg/hr | |
| FentaNYL | FILM, EXTENDED RELEASE, TRANSDERMAL | 25 mcg/hr | |
| FentaNYL | FILM, EXTENDED RELEASE, TRANSDERMAL | 50 mcg/hr | |
| FentaNYL | FILM, EXTENDED RELEASE, TRANSDERMAL | 75 mcg/hr | |
| FentaNYL | FILM, EXTENDED RELEASE, TRANSDERMAL | 100 mcg/hr | |
| FentaNYL Citrate | LOZENGE, ORAL TRANSMUCOSAL | 200 mcg | |
| FentaNYL Citrate | LOZENGE, ORAL TRANSMUCOSAL | 400 mcg | |
| FentaNYL Citrate | LOZENGE, ORAL TRANSMUCOSAL | 600 mcg | |
| FentaNYL Citrate | LOZENGE, ORAL TRANSMUCOSAL | 800 mcg | |
| FentaNYL Citrate | LOZENGE, ORAL TRANSMUCOSAL | 1200 mcg | |
| FentaNYL Citrate | LOZENGE, ORAL TRANSMUCOSAL | 1600 mcg | |
| FentaNYL Citrate | SOLUTION, INJECTABLE | 10 mcg/mL-0.9% | |
| FentaNYL Citrate | SOLUTION, INJECTABLE | 50 mcg/mL | |
| Fentora | TABLET, BUCCAL | 200 mcg | |
| Duragesic |
Last updated: Feb. 25, 2025
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Do Not Crush: Lozenge/Buccal Tablet
- Black Box Warning: Use in chronic pain only
- REMS: Fentanyl -Transmucosal Immediate Release; Opioid Analgsic REMS
Class II
Fentanyl patch for chronic pain only - do NOT use in opioid naïve patients (FDA).
Fentanyl may be given via hypodermoclysis (HDC/subcutaneous infusion). See Procedure 904.4991
Legacy Guidelines:
Use in mechanically ventilated patients, See the Pain, Agitation and Delirium Protocol (aka "PAD") Protocol 901.6008
For pediatric long term sedation weaning: See Protocol 912.6016
Infusion Concentrations and Ranges:
Adult General Titration Ranges and Administration (weight based dosing): See Handout (updated Aug 2016)